Childen's Hospital Boston  300 Longwood Avenue
Boston, MA 02115
(617) 355-6000
 X
My Child Has:
Oligodendroglioma
Programs that treat this condition
 Brain Tumor Program  
What is oligodendroglioma?
An oligodendroglioma is low-grade tumor arising from a type of cell of the central nervous system known as a glial cell. These tumors originate from a specific type of glial cell known as an oligodendrocyte. Oligodendrocytes make up a supportive network for the nerves of the brain and spinal column.

Oligodendrogliomas account for only approximately 2 percent of all pediatric brain tumors. They occur most commonly in the frontal lobe (the section of the brain that influences personality and reasoning), but may occur anywhere along the brain and spinal cord.

As you read further below, you will find general information about oligodendrogliomas. If you would like to view summary information about brain tumors first, see the overview on brain tumors.

What causes an oligodendroglioma?
Children with certain genetic syndromes, including neurofibromatosis type I and tuberous sclerosis, are at higher risk of developing tumors of glial origin, including oligodendrogliomas. The vast majority of children with oligodendrogliomas, however, develop these tumors spontaneously, meaning there is no identifiable cause.
What are the symptoms of an oligodendroglioma?
Due to the relatively slow growth rate of oligodendrogliomas, children with these tumors tend to present to the doctor with symptoms that have been occurring for many months. Some children, however, will have a more sudden onset of symptoms. The following are the most common symptoms of an oligodendroglioma, however each child may experience symptoms differently. Common symptoms may include:
  • many present with symptoms of increased pressure within the brain. These symptoms include:
    • headache (generally upon awakening in the morning)
    • vomiting
    • fatigue
  • others may experience seizures and weakness on one side of the body
The symptoms of a brain tumor may resemble other conditions or medical problems. Always consult your child's physician for a diagnosis.
How is an oligodendroglioma diagnosed?
Diagnostic procedures for an oligodendroglioma may include:
  • physical examination - the child may demonstrate evidence of increased pressure in the brain
  • computerized tomography scan (also called a CT or CAT scan) - a diagnostic imaging procedure that uses a combination of x-rays and computer technology to produce cross-sectional images (often called slices), both horizontally and vertically, of the body. CT scans are more detailed than general x-rays. For oligodendroglioma, a CT scan of the brain is usually done.
  • magnetic resonance imaging (MRI) - a diagnostic procedure that uses a combination of large magnets, radiofrequencies, and a computer to produce detailed images of organs and structures within the body. For oligodendroglioma, MRIs of the brain and spine are usually done.
  • electroencephalogram (EEG) - for children experiencing seizures, this procedure records the brain's continuous, electrical activity by means of electrodes attached to the scalp, and helps identify and localize seizure activity to a particular section of the brain
  • biopsy -a tissue sample from the tumor taken through a needle during a simple surgical procedure performed by a surgeon to confirm the diagnosis
What are the treatments for oligodendroglioma?
Specific treatment for an oligodendroglioma will be determined by your child's physician based on:
  • your child's age, overall health, and medical history
  • type, location, and size of the tumor
  • extent of the disease
  • your child's tolerance for specific medications, procedures, or therapies
  • how your child's doctors expects the disease to progress
  • your opinion or preference
Treatment may include (alone or in combination):
  • surgery - the primary treatment is maximum surgical removal of the tumor. Tumors that are completely removed may not require further therapy other than serial MRIs to monitor for tumor re-growth.
  • radiation therapy - for tumors that are incompletely removed and then increase in size or for tumors that recur, the recommended treatment is radiation therapy to the site of the tumor. Radiation therapy uses high-energy rays (radiation) from a specialized machine to damage or kill cancer cells and shrink tumors.
How are side effects managed?
Children with oligodendrogliomas may have side effects related to the tumor itself and its treatment. Symptoms at the time of diagnosis related to increased pressure within the brain, such as headache, vomiting and lethargy, and/or from compression of the nerves that control movement of the extremities, are often relieved by surgical debulking of the tumor. Dexamethasone, an oral steroid, is often used, especially in the post-operative period, to assist in controlling systems of increased pressure within the brain, as well as any additional tissue swelling that may occur post-operatively.

Radiation therapy may cause swelling related to tissue inflammation. This inflammation may lead to symptoms of headache or difficulty with coordination. These symptoms, if significant, may be treated with the oral medication dexamethasone.

Children with seizures are treated with anti-seizure medications to control or, in some cases, eliminate these symptoms.

What is the expected outcome after treatment for oligodendroglioma?
Oligodendrogliomas are associated with a high rate of cure. Data suggest a 20-year survival rate of approximately 80 percent. Greater degree of surgical removal is associated with a higher rate of cure.
What about progressive or recurrent disease?
The recommended treatment for progressive/recurrent oligodendroglioma is radiation therapy. Dana-Farber Cancer Institute is one of nine institutes in the nation belonging to the Pediatric Brain Tumor Consortium. The consortium is dedicated to the development of new and innovative treatments for children with progressive/recurrent brain tumors not responsive to standard therapies. Children with progressive/recurrent oligodendroglioma would be eligible for a number of experimental therapies available through the consortium.
What is the latest research on oligodendroglioma?
Children's Hospital and Dana-Farber Cancer Institute are conducting numerous research studies that will help clinicians better understand and treat oligodendroglioma. For more information on current research, see the Brain Tumor Program.
 X
 X The information on this website should not be taken as medical advice,
which can only be given to you by your personal health care professional.
 X
 X Copyright © Children's Hospital Boston. All rights reserved.